Annals of Occupational Hygiene Advance Access originally published online on August 26, 2005
Annals of Occupational Hygiene 2005 49(7):629-637; doi:10.1093/annhyg/mei042
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 British Occupational Hygiene Society Published by Oxford University Press
Original Article |
Surface Contamination of Cyclophosphamide Packaging and Surface Contamination with Antineoplastic Drugs in a Hospital Pharmacy in Sweden
1 Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, University Hospital, SE-221 85 Lund, Sweden; 2 Karolinska Pharmacy, Karolinska University Hospital, SE-171 76 Stockholm, Sweden; 3 Department of Woman and Child Health, Karolinska Institutet, SE-171 77 Stockholm, Sweden
* Author to whom correspondence should be addressed. Tel: +46-46-173193; fax: +46-46-143702; e-mail: maria.hedmer{at}med.lu.se
Workplaces, e.g. hospital pharmacies and hospital departments, where antineoplastic drugs are handled might be contaminated with these drugs, and pharmacy personnel and health care workers may be exposed. In this study potential sources for exposure of antineoplastic drugs were investigated. Unbroken drug vials and tablet blister packages, both containing cyclophosphamide (CP) and their outer packaging were wipe sampled. Analysis was performed by liquid chromatography combined with tandem mass spectrometry (LC-MS/MS). The result showed that almost every part of the primary packaging was contaminated with CP and ifosfamide (IF). However, the amounts of CP and IF were low, and most likely not harmful for the personnel handling these packaging in association with drug preparation. The contamination must originate from the pharmaceutical manufacturer. Different surfaces in the preparation unit of a Swedish hospital pharmacy were also investigated at two different occasions by wipe sampling. In the preparation unit CP and IF were found as contaminants on the majority of the investigated surfaces. After the first measurement the hospital pharmacy improved its routines. Lower amounts of CP and IF were detected at the second measurement. A low degree of contamination with CP and IF was also detected on the floor outside the preparation unit and this indicated a small distribution of antineoplastic drugs to the surroundings.
Keywords: antineoplastic drugs • contamination • cyclophosphamide • environmental monitoring • ifosfamide • packaging • pharmacy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Touzin, J.-F. Bussieres, E. Langlois, M. Lefebvre, and A. Metra Pilot Study Comparing the Efficacy of Two Cleaning Techniques in Reducing Environmental Contamination with Cyclophosphamide Ann. Hyg., January 29, 2010; (2010): meq004v1 - meq004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schierl, A. Bohlandt, and D. Nowak Guidance Values for Surface Monitoring of Antineoplastic Drugs in German Pharmacies Ann. Hyg., October 1, 2009; 53(7): 703 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Touzin, J.-F. Bussieres, E. Langlois, M. Lefebvre, and C. Gallant Cyclophosphamide Contamination Observed on the External Surfaces of Drug Vials and the Efficacy of Cleaning on Vial Contamination Ann. Hyg., November 1, 2008; 52(8): 765 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Connor and M. A. McDiarmid Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings CA Cancer J Clin, November 1, 2006; 56(6): 354 - 365. [Abstract] [Full Text] [PDF]
|
|